These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30681907)

  • 1. Role of gut metabolism of adrenal corticosteroids and hypertension: clues gut-cleansing antibiotics give us.
    Morris DJ; Brem AS
    Physiol Genomics; 2019 Mar; 51(3):83-89. PubMed ID: 30681907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
    Morris DJ; Latif SA; Hardy MP; Brem AS
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alternative explanation of hypertension associated with 17α-hydroxylase deficiency syndrome.
    Morris DJ; Latif SA; Brem AS
    Steroids; 2014 Jan; 79():44-8. PubMed ID: 24176792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 11β-hydroxysteroid dehydrogenase functions by the cloud of endogenous metabolites in a local microenvironment: The glycyrrhetinic acid-like factor (GALF) hypothesis.
    Morris DJ; Brem AS; Odermatt A
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105988. PubMed ID: 34464733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous selective inhibitors of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2 of adrenal origin.
    Latif SA; Pardo HA; Hardy MP; Morris DJ
    Mol Cell Endocrinol; 2005 Nov; 243(1-2):43-50. PubMed ID: 16188377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do humans have two glucocorticoids: A question of intestinal fortitude.
    Morris DJ
    Steroids; 2015 Oct; 102():32-8. PubMed ID: 26144050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era.
    Morris DJ; Ridlon JM
    Steroids; 2017 Sep; 125():1-13. PubMed ID: 28624548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ELISA Technique and Human Microsomes in the Search for 11
    Kupczyk D; Studzińska R; Bilski R; Woźniak A
    Biomed Res Int; 2019; 2019():5747436. PubMed ID: 31214617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local cortisol/corticosterone activation in skin physiology and pathology.
    Terao M; Katayama I
    J Dermatol Sci; 2016 Oct; 84(1):11-16. PubMed ID: 27431412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uninephrectomy reduces 11β-hydroxysteroid dehydrogenase type 1 and type 2 concomitantly with an increase in blood pressure in rats.
    Lauterburg M; Escher G; Dick B; Ackermann D; Frey FJ
    J Endocrinol; 2012 Sep; 214(3):373-80. PubMed ID: 22739210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp.
    Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH
    Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate.
    Ge RS; Dong Q; Niu EM; Sottas CM; Hardy DO; Catterall JF; Latif SA; Morris DJ; Hardy MP
    Endocrinology; 2005 Jun; 146(6):2657-64. PubMed ID: 15761036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity.
    London E; Castonguay TW
    J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development.
    Ge R; Huang Y; Liang G; Li X
    Curr Med Chem; 2010; 17(5):412-22. PubMed ID: 20015040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.
    Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH
    J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hypertensiogenetic steroid 19-nor-progesterone does not influence cortisol inactivation by 11beta-hydroxysteroid dehydrogenase type 2.
    Lepenies J; Stewart PM; Quinkler M
    Clin Exp Hypertens; 2009 Jun; 31(4):376-9. PubMed ID: 19811365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.